Assignee
GILEAD BIOLOGICS INC
US·9 granted patents·11 pending applications·96 citations·filing 2011–2019
Top patents by PatentIndex Score
20 records- 0194US8927700B2Catalytic domains from lysyl oxidase and LOXL2GILEAD BIOLOGICS INC·Filed 2013·Granted Jan 6, 2015·17 cites·10 claims
- 0293US8658167B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2012·Granted Feb 25, 2014·19 cites·30 claims
- 0392US9176139B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2013·Granted Nov 3, 2015·16 cites·60 claims
- 0492US8377443B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2011·Granted Feb 19, 2013·21 cites·7 claims
- 0589US10800857B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2019·Granted Oct 13, 2020·2 cites·16 claims
- 0686US9120863B2Nucleic acids encoding antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2013·Granted Sep 1, 2015·7 cites·30 claims
- 0784US9260532B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2013·Granted Feb 16, 2016·6 cites·11 claims
- 0880US9732156B2Methods of treating rheumatoid arthritis using antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2013·Granted Aug 15, 2017·8 cites·20 claims
- 0964US10494443B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2016·Granted Dec 3, 2019·0 cites·22 claims
- 1064US2014128284A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 1164US2014349309A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 1261US2018086845A1Nucleic acids encoding antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1357US2016185877A1Lox and loxl2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 1457US2016122437A1Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1556US2016159923A1Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 1656US2017183421A1Method of detecting human matrix metalloproteinase 9 using antibodiesGILEAD BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1756US2014255951A1Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use thereforGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 1856US2014302524A1Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use thereforGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 1942US2018002446A1Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2026US2015239988A1Antibodies to matrix metalloproteinase 9 and methods of use thereofGILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GILEAD BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →